Endocan Corp Current Valuation vs. Book Value Per Share
| ENDO Stock | USD 0.0001 0.00 0.00% |
For Endocan Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Endocan Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Endocan Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Endocan Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Endocan Corp over time as well as its relative position and ranking within its peers.
Endocan |
Endocan Corp Book Value Per Share vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Endocan Corp's current stock value. Our valuation model uses many indicators to compare Endocan Corp value to that of its competitors to determine the firm's financial worth. Endocan Corp is rated # 3 in current valuation category among its peers. It also is rated # 3 in book value per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endocan Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endocan Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Endocan Current Valuation vs. Competition
Endocan Corp is rated # 3 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Specialty Chemicals industry is currently estimated at about 516.71 Billion. Endocan Corp adds roughly 1.87 Million in current valuation claiming only tiny portion of equities listed under Specialty Chemicals industry.
Endocan Book Value Per Share vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Endocan Corp |
| = | 1.87 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Endocan Corp |
| = | (0.02) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Endocan Book Value Per Share Comparison
Endocan Corp is currently under evaluation in book value per share category among its peers.
Endocan Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Endocan Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Endocan Corp will eventually generate negative long term returns. The profitability progress is the general direction of Endocan Corp's change in net profit over the period of time. It can combine multiple indicators of Endocan Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.
Endocan Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Endocan Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Endocan Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Endocan Corp's important profitability drivers and their relationship over time.
Use Endocan Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endocan Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will appreciate offsetting losses from the drop in the long position's value.Endocan Corp Pair Trading
Endocan Corp Pair Trading Analysis
The ability to find closely correlated positions to Endocan Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endocan Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endocan Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endocan Corp to buy it.
The correlation of Endocan Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Endocan Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Endocan Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Endocan Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Endocan Corp position
In addition to having Endocan Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Endocan Pink Sheet
To fully project Endocan Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Endocan Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Endocan Corp's income statement, its balance sheet, and the statement of cash flows.